From The Economic Times
Center-Right Owned by Bennett, Coleman & Co.Cipla expects US business to draw support from upcoming product pipeline
RSS excerpt
Cipla reported a significant decline in its consolidated net profit for the second quarter of FY27. The company's North American revenue fell by 19% due to increased competition impacting sales of generic Revlimid. However, Cipla anticipates that its upcoming product pipeline will support…